AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BioLineRx Ltd. M&A Activity 2017

Mar 23, 2017

6692_rns_2017-03-23_62c1d33b-8150-4927-b8f4-c4efa0537c3e.htm

M&A Activity

Opens in your device viewer

_________ false


�� "�	2 380
BIOLINE RX LTD
Corporation no: 513398750	9253
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	23/03/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-023992	Time of broadcast: 12:51 12:42:23

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline
6-K_Agalimmune_230317_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/03/2017
Address: HaMa'ayan 2 , Modi'in 7177871 , Israel Tel: 08-6429100 , Fax: 08-6429101
E-mail address: [email protected] Company site: www.biolinerx.com

Previous names of reporting entity:

Name of the Signatory: Kotler Norman Harold Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company:
Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: [email protected] 1
Israel